Ignite Creation Date:
2025-12-24 @ 5:47 PM
Ignite Modification Date:
2026-02-03 @ 9:11 PM
Study NCT ID:
NCT01613768
Status:
COMPLETED
Last Update Posted:
2018-09-28
First Post:
2012-06-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Eribulin Mesylate in Treating Patients With Recurrent or Metastatic Salivary Gland Cancer
Sponsor:
University of Washington
Organization: